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Abstract
A family history of type 2 diabetes (T2D) confers a high risk of developing the disease, independent of that due to other common risk
factors. Postprandial state is a pro-inflammatory condition associated with a transiently impaired endothelial function; an increased oxi-
dative stress is considered as a mediator of such effects in T2D. We evaluated the short-term effect of a lipid meal on markers of early
vascular damage in subjects at risk of developing T2D. A total of thirty-two healthy volunteers, divided according to the presence
(FHDþ) or absence (FHD2) of a family history of T2D, underwent a fatty meal test. We measured the monocyte mRNA expressions
of IL-6, IL-8 and IL-1b, and IL-6, soluble CD40 ligand (sCD40L), vascular cellular adhesion molecule-1 (VCAM-1), intracellular adhesion
molecule-1 (ICAM-1) and nitrotyrosine plasma concentrations at baseline and in the post-meal phase, relating them to the lipid profile
and other biochemical parameters. The basal expression of the cytokines did not differ in FHD2 and FHDþ subjects; neither was it
modified by the meal ingestion. IL-6 and sCD40L plasma levels, similar in the two groups in the fasting state, did not vary after the
meal. VCAM-1 and ICAM-1 increased in FHDþ subjects but not in FHD2 subjects. Nitrotyrosine, similar between the FHD2 and
FHDþ subjects at baseline, increased more in FHDþ subjects than in FHD2 subjects after the meal. In conclusion, the presence of a famil-
ial history of T2D confers an abnormal endothelial activation after an oral lipid meal, coupled with an increased oxidative stress, supporting
the hypothesis of an early endothelial dysfunction already present in healthy individuals prone to develop T2D.
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First-degree relatives of individuals with type 2 diabetes (T2D)
are a good human model to test for mechanisms involved in
the early development of atherosclerosis, as long before
developing overt diabetes, they show insulin resistance, dysli-
pidaemia, increased abdominal adiposity and muscle TAG
content, and reduced first-phase insulin secretion in response
to glucose(1,2).
Postprandial hyperlipaemia may promote coronary and car-
otid artery disease; moreover, the magnitude of postprandial
triacylglycerolaemia is related to the intima-media thickness
of the carotid arteries, a surrogate marker for early athero-
sclerosis(3,4). Chronic consumption of fat-rich diets leads to
atherosclerosis, inducing endothelial dysfunction and other
changes in the vascular system(5,6); these alterations are
accompanied by an increased production of some inflamma-
tory molecules. Among these, IL-1b promotes migration and
development of smooth muscle cells within the atherosclerotic
lesion and stimulates vascular endothelial growth factor
synthesis, thus contributing to the development of diabetic
microangiopathy(7); IL-6 is implicated in endothelial
dysfunction and vascular inflammation, and promotes insulin
resistance(8); IL-8 mediates leucocyte adhesion to endothelial
cells and infiltration into the arterial wall(9); CD40 promotes
restenosis after vascular injury, and enhanced expression of
the CD40 ligand in platelets and elevated plasma levels of
the soluble CD40 ligand (sCD40L) have been reported in
subjects at high risk of developing CHD(10–13).
Circulating levels of intracellular adhesion molecule-1
(ICAM-1) and vascular cellular adhesion molecule-1 (VCAM-1)
increase in diabetic patients(14) and predict the development
of the disease(15). Evidence suggests that postprandial hyperli-
paemia may stimulate the release of these molecules, with oxi-
dative stress as the putative mediator of such effect(16) and
nitrotyrosine as a good marker of peroxynitrite and nitrosative
stress generation. However, there is no information on the
acute effects of a fat-rich meal on the appearance of these
markers of early endothelial damage in subjects at risk of
developing T2D due to a positive family history of the disease.
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We examined whether a lipid-rich meal modulates the
synthesis of cytokines and stimulates the release of adhesion
factors and parameters of oxidative stress in young healthy
offspring of diabetic patients.
Subjects and methods
The participants in the study were sixteen non-smoking,
healthy, young volunteers with one or both parents with
T2D (FHDþ) who were consecutively enrolled on a voluntry
basis among post-doctoral students matching the inclusion
criteria and compared with other sixteen subjects of similar
age and BMI but without a family history of T2D (FHD2).
Inclusion criteria were negative history of chronic illness,
normal glucose tolerance (assessed by an oral glucose toler-
ance test) and absence of clinical or biochemical signs of
ongoing inflammation (highly sensitive C-reactive protein
,0·5 mg/l).
All subjects were asked to follow the same written diet for
the 2 weeks preceding the study, a diet of 5842 kJ
(1400 kcal) with 16 % protein, 58 % carbohydrate and 24 %
fat. Alcohol consumption was moderate in fourteen subjects
(,60 g/week) and occasional in six, and four were teetotal-
lers. None of the participants practised strenuous physical
exercise or was taking any medication. The present study
was conducted according to the guidelines laid down in the
Declaration of Helsinki, and all procedures were approved
by the Institutional Review Board of the University of Pisa
(Pisa, Italy). Written informed consent was obtained from all
subjects.
Participants were admitted early in the morning after a 12 h
fast. Blood pressure was measured four times in the sitting
position after a 10 min rest; the mean of the last two measure-
ments was used for statistical analysis. A blood sample was
taken before the test meal; then, they consumed (within
15 min) a fat-enriched breakfast (butter 25 g, bread 100 g and
10 % fat ham 50 g). The energy content of the meal was
3051 kJ (730 kcal), with 13 % of energy from protein, 35 %
from carbohydrate and 52 % from fat. At 2 and 6 h after the
meal, blood samples were drawn for the isolation of mono-
cytes and the determination of biochemical parameters and
inflammatory molecules. Some measurements were also
repeated after 12 h.
Biochemical parameters
Plasma cholesterol and TAG concentrations were measured by
standard enzymatic assays. HDL-cholesterol was measured
after precipitation of apoB-containing lipoproteins, and
LDL-cholesterol was calculated by the Friedewald formula.
Plasma NEFA assay was performed by a spectrophotometric
method (Wako Chemicals, Neuss, Germany), plasma insulin
by RIA (Linco Research, Inc., St Charles, MO, USA), with an
intra-assay CV of 3·2 % and an inter-assay CV of 4·0 %.
Monocyte isolation
Blood was collected in vacutainers containing sodium hepar-
inate, diluted (1:1) with sterile Dulbecco’s PBS, slowly laid
on a warm Ficoll-Hypaque solution (Histopaque 1077;
Sigma-Aldrich, Milan, Italy) and centrifuged at 950 g for
20 min. To separate monocytes from lymphocytes, 1 ml of
the cell suspension was added to a hyperosmotic Percoll sol-
ution (Sigma-Aldrich) in 3 ml final volume and centrifuged at
580 g for 15 min. Collected cells were added with Dulbecco’s
PBS up to 15 ml, centrifuged at 350 g for 7 min, thus obtaining
a monocyte-enriched suspension. To discard platelets and
dead cells, in each centrifuge tube, 3 ml of the iso-osmotic Per-
coll solution was overlaid with 1 ml of the monocyte-enriched
suspension and centrifuged at 350g for 15 min; newly resus-
pended in Dulbecco’s-PBS and finally centrifuged at 350 g
for 7 min, storing the pellet at 2808C.
Cytokine gene expression
IL-1b, IL-6 and IL-8 mRNA levels were evaluated by RT-PCR
from total RNA extracts obtained by the RNeasy mini kit
(Qiagen, Milano, Italy). Total RNA was reverse-transcribed
using the ImProm IIe RT-PCR System (Promega, Madison,
WI, USA). Amplification primers for IL-1b, IL-6 and IL-8 and
the housekeeping gene glyceraldehyde 3-phosphate dehydro-
genase were as follows: IL-1b sense 50-GGATATGGAGCAACA-
AGTGG-30, antisense 50-ATGTACCAGTTGGGGAACTG-30; IL-6
sense 50-GTCTCCTCATTGAATCCAGATTGG-30, antisense
50-AGCTCAGCTATGAACTCCTTCTC-30; IL-8 sense 50-TCTTGC-
ACAAATATTTGATGC-30, antisense 50-CCACTGTGCCTTGG-
TTTC-30; glyceraldehyde 3-phosphate dehydrogenase sense
50-GTGAGGAGGGGAGATTCA-30, antisense 50-GCATCCTGG-
GCTACACTG-30. Oligonucleotides were synthesised by
M-Medical Genenco-Life Science (Firenze, Italy). Amplification
was carried out with a Platinum PCR SuperMix High Fidelity
kit (Invitrogen, Milano, Italy). Products were separated on
1 % agarose, stained with ethidium bromide and quantified
by scanning densitometry.
To more precisely compare gene expression between the
two groups, real-time PCR analysis was also performed. For
first-strand complementary DNA synthesis, 1mg RNA was
reverse-transcribed in a 20ml volume using random hexamers
as primers, according to the manufacturer’s instructions (First
Strand complementary DNA Synthesis Kit for RT-PCR; AMV,
Roche, Indianapolis, IN, USA). The primers and probe
sequences were obtained from PE Applied Biosystems (Pre-
Developed TaqMan Assay Reagents Control Kits; Foster City,
CA, USA). The following assay ID were used: IL-1b,
Hs00174097m1; IL-6, Hs00174131m1; IL-8, Hs00174103m1;
glyceraldehyde 3-phosphate dehydrogenase, Hs99999905m1.
PCR amplifications were performed in a total volume of
20ml containing 20 ng of the complementary DNA sample,
200 nmol/l of each primer, 100 nmol/l of the corresponding
probe, 12·5ml of the TaqMan Universal PCR Master Mix. For
each reaction, the polymerase was activated by preincubation
at 958C for 10 min. Amplification was then performed by forty
cycles of switching between 958C for 15 s and 608C for 60 s.
The quantity of each complementary DNA sample was nor-
malised to the housekeeping gene glyceraldehyde 3-phos-
phate dehydrogenase.
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Release of markers of inflammation and oxidative stress
IL-6, sCD40L, soluble VCAM-1, soluble ICAM-1 and plasma
nitrotyrosine concentrations were analysed using commer-
cially available ELISA (R&D Systems, Abingdon, UK and Cell
Sciences, Canton, MA, USA).
Statistical analysis
Given the exploratory nature of the study, no prespecified
outcome variable was selected, and a formal power analysis
was not carried out. Plasma insulin and TAG levels were
non-normally distributed and were therefore log-transformed
for use in statistical analyses. Comparisons of baseline data
were performed by the unpaired Student’s t test. Differential
changes between the two groups over time were tested by
two-way ANOVA for repeated measures; results are given as
significance of the time factor and the group £ time interaction
term. Simple and multiple regression analyses were performed
by standard methods. Data were analysed using the StatView
software package (SAS Institute Inc., Cary, NC, USA).
Results
FHDþ subjects were slightly older and heavier than FHD2
subjects and showed a trend towards higher blood pressure
and cholesterol levels; however, a slightly higher plasma
TAG concentration was the only significantly different variable
between the two groups (data not shown).
Following the test meal, TAG, NEFA and insulin all rose sig-
nificantly, while total cholesterol and plasma glucose concen-
trations remained stable (Table 1). These changes were similar
in the two groups.
No significant difference in the monocyte expression of the
three cytokines was found between the FHDþ and FHD2
subjects, either basally or at 6 h post-meal, nor did the meal
alter the baseline expression pattern. This observation was
confirmed by the values obtained by real-time PCR: no differ-
ence in the expressions of IL-6, IL-8 and IL-1b before and after
the meal was observed either in FHDþ or FHD2 subjects
(Fig. 1). Moreover, median plasma IL-6 levels, similar in the
two groups in the fasting state (0·43 (interquartile range
0·27) pg/ml in FHD2 subjects and 0·57 (interquartile range
0·47) pg/ml in FHDþ subjects), did not change significantly
at 2, 6 or 12 h (0·56 (interquartile range 0·33) v. 0·53 (interquar-
tile range 0·49); 0·70 (interquartile range 0·55) v. 0·63 (inter-
quartile range 0·55); 0·54 (interquartile range 0·45) v. 0·58
(interquartile range 0·58) pg/ml, all P¼NS for either a group
or group £ time interaction). Median sCD40L levels followed
the same trend, without any differences between the two
groups either in the fasting state (2·48 (interquartile range
1·77) ng/ml in FHD2 subjects and 1·69 (interquartile range
4·28) ng/ml in FHDþ subjects) or in the post-meal state
(2·06 (interquartile range 1·71) v. 1·68 (interquartile range
3·92) and 2·07 (interquartile range 1·83) v. 1·27 (interquartile
range 3·12) at 2 and 6 h, respectively, both P¼NS). After
12 h, median sCD40L concentration was 2·15 (interquartile
range 1·21) ng/ml in FHD2 subjects and 1·13 (interquartile
range 2·93)) ng/ml in FHDþ subjects, P¼NS for either a
group or group £ time interaction.
With regard to the serum levels of the subjects’ adhesion
molecules, neither VCAM-1 nor ICAM-1 changed in FHD2
subjects, while both increased in FHDþ subjects significantly,
though still within the normal range (P#0·01 for the group £
time interaction; Fig. 2). For both markers, the between-group
difference persisted after adjusting (by multivariate regression)
for age, insulin, total cholesterol or TAG. At 12 h, VCAM-1 and
ICAM-1 tended to decline but were still significantly higher in
FHDþ subjects. Nitrotyrosine levels were superimposable
between the FHD2 and FHDþ subjects at baseline but
rose significantly higher in FHDþ subjects than in FHD2
subjects at 2 and 6 h post-meal (Fig. 2); after 12 h, this differ-
ence was cancelled. In FHDþ subjects, nitrotyrosine was
directly related to NEFA (r 0·53, P,0·0001), TAG (r 0·32,
P¼0·03) and insulin (r 0·36, P¼0·01) levels.
In the whole study group, there was a positive correlation
between the meal-induced DVCAM-1 and the baseline
(r 0·450, P¼0·0098) and post-meal (r 0·514, P¼0·0031) TAG
levels, while meal-induced DICAM-1 was significantly related
to meal-induced nitrotyrosine (r 0·537, P¼0·0015).
Table 1. Biochemical parameters before and after a fat-enriched breakfast in subjects with (FHDþ ) or without (FHD2 ) a family
history of type 2 diabetes
(Mean values and standard deviations)
Pre 2 h 6 h P*
Group Mean SD Mean SD Mean SD G T
Glucose (mmol/l) FHD2 4·7 0·4 4·8 0·2 4·9 0·3 NS NS
FHDþ 4·8 0·4 4·9 0·2 4·9 0·3
Cholesterol (mmol/l) FHD2 4·90 1·01 4·95 0·96 4·87 0·88 NS NS
FHDþ 5·34 1·04 5·39 1·01 5·31 0·98
Insulin (pmol/l) FHD2 65 25 109 27 54 24 NS ,0·0001
FHDþ 74 49 119 38 62 28
TAG (mmol/l) FHD2 0·74 0·19 0·90 0·20 0·84 0·21 0·02 ,0·0001
FHDþ 0·96 0·24 1·13 0·35 1·22 0·40
NEFA (mmol/l) FHD2 401 231 485 171 614 196 NS ,0·0001
FHDþ 493 254 594 264 744 296
T, time; G, group £ time interaction.
* P value for the effect of T and G.
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Discussion
In the present study, we show that young healthy subjects
with a parental history of T2D have a normal response to an
oral fat load in terms of inflammatory cytokines expression
and release; in contrast, the response of the circulating
adhesion molecules is modestly but consistently increased in
parallel with a meal-induced rise in nitrotyrosine, an index
of oxidative stress. These data do not confirm those by
Nappo et al.(16), who found an enhanced IL-6 and TNF-a
release after either a glucose or a fat load also in normal sub-
jects. One explanation for this discrepancy is that our subjects
were carefully selected for being free from confounding fac-
tors such as glucose intolerance, obesity or hypertension.
The test meal that we used did not induce changes in either
IL-1b, a cytokine mainly released by neutrophils that might
play a role in inducing b-cell apoptosis(17), or IL-6, a marker
of insulin resistance whose levels have been shown to predict
the risk of incident diabetes(18,19), unmodified by a fatty meal
in normal individuals as reported by Poppitt et al.(20). This
suggests that family history of diabetes per se, in the absence
of overt metabolic abnormalities, does not confer suscepti-
bility to an inflammatory response to an acute stimulus rep-
resented by a lipid oral load. Similarly, the pro-inflammatory
mediator sCD40L, which is expressed in CD4þT cells and
activated platelets and participates in several inflammatory
and pro-atherothrombotic functions(21), was unaffected by
an oral fat load in both groups, implying that familial predis-
position to diabetes does not add prothrombotic risk.
At variance with the observations made by Ceriello et al.(22),
VCAM-1 and ICAM-1 did not increase post-meal in FHD2
subjects, but did so in FHDþ subjects, even remaining
within the normal range, suggesting an early defect in vascular
reactivity and endothelial function in these subjects, possibly
outlined by the oral fat load. In this respect, the direct relation-
ship between TAG and VCAM-1 appears of particular interest,
supporting the role of circulating lipids in endothelial func-
tion(23). We actually show that not only post-meal TAG but
even fasting TAG might play a role in determining VCAM-1
variation in the post-absorptive phase, reinforcing the role of
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Fig. 1. Representative RT-PCR for the monocyte mRNA expressions of IL-6,
IL-8 and IL-1b in two subjects without a family history of type 2 diabetes
(FHD2 ; no. 1 and 2, representative of sixteen) and two subjects with a
family history of type 2 diabetes (FHDþ ; no. 3 and 4, representative of six-
teen) in the fasting state (pre) and 6 h after a fat-enriched breakfast (post),
and the quantitative evaluation of IL-6, IL-8 and IL-1b expressions in sixteen
FHD2 and sixteen FHDþ subjects measured by real-time PCR in the
fasting state (pre) and 6 h after a fat-enriched breakfast (post). Values are
means, with standard errors represented by vertical bars. , FHD2 ; ,
FHDþ ; M, marker.
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Fig. 2. Circulating levels of vascular cellular adhesion molecule-1 (VCAM-1),
intracellular adhesion molecule-1 (ICAM-1) and nitrotyrosine at baseline and
2, 6 and 12 h after a fat-enriched breakfast in subjects with (FHDþ ) and
without (FHD2 ) a family history of type 2 diabetes. Values are means, with
standard errors represented by vertical bars. * Mean values were significantly
different for the group £ time interaction along the whole test (P#0·01). ,
FHD2 ; , FHDþ .
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lipid metabolism as a strong determinant of endothelial func-
tion. The rise in nitrotyrosine levels (a useful marker of both
peroxynitrite and nitric oxide activity) in the FHDþ subjects
and their relation to TAG and FFA levels resonate with the
concept that NEFA increase oxidative stress generation in
humans(24). Further support to such a hypothesis might
come from the relationship between the variation of ICAM-1
and nitrotyrosine levels, while such a correlation with
VCAM-1 is lacking. This may be referred to the differences
between these two adhesion molecules, given that ICAM-1 is
mostly expressed at the level of endothelial cells, and its
expression is enhanced by a variety of pro-inflammatory
stimuli(25).
In conclusion, in young healthy subjects, parental diabetes
appears to be associated with the evidence of abnormal endo-
thelial reactivity and increased oxidative stress in response to
an acute stimulus. The present study has several limitations,
mainly its exploratory, hypothesis-generating nature and the
small sample size. These observations await to be confirmed
in larger cohorts of subjects.
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